Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Alveolar type II epithelial cell FASN maintains lipid homeostasis in experimental COPD
Li-Chao Fan, Keith McConn, Maria Plataki, Sarah Kenny, Niamh C. Williams, Kihwan Kim, Jennifer A. Quirke, Yan Chen, Maor Sauler, Matthias E. Möbius, Kuei-Pin Chung, Estela Area Gomez, Augustine M.K. Choi, Jin-Fu Xu, Suzanne M. Cloonan
Li-Chao Fan, Keith McConn, Maria Plataki, Sarah Kenny, Niamh C. Williams, Kihwan Kim, Jennifer A. Quirke, Yan Chen, Maor Sauler, Matthias E. Möbius, Kuei-Pin Chung, Estela Area Gomez, Augustine M.K. Choi, Jin-Fu Xu, Suzanne M. Cloonan
View: Text | PDF
Research Article Metabolism Pulmonology

Alveolar type II epithelial cell FASN maintains lipid homeostasis in experimental COPD

  • Text
  • PDF
Abstract

Alveolar epithelial type II (AEC2) cells strictly regulate lipid metabolism to maintain surfactant synthesis. Loss of AEC2 cell function and surfactant production are implicated in the pathogenesis of the smoking-related lung disease chronic obstructive pulmonary disease (COPD). Whether smoking alters lipid synthesis in AEC2 cells and whether altering lipid metabolism in AEC2 cells contributes to COPD development are unclear. In this study, high-throughput lipidomic analysis revealed increased lipid biosynthesis in AEC2 cells isolated from mice chronically exposed to cigarette smoke (CS). Mice with a targeted deletion of the de novo lipogenesis enzyme, fatty acid synthase (FASN), in AEC2 cells (FasniΔAEC2) exposed to CS exhibited higher bronchoalveolar lavage fluid (BALF) neutrophils, higher BALF protein, and more severe airspace enlargement. FasniΔAEC2 mice exposed to CS had lower levels of key surfactant phospholipids but higher levels of BALF ether phospholipids, sphingomyelins, and polyunsaturated fatty acid–containing phospholipids, as well as increased BALF surface tension. FasniΔAEC2 mice exposed to CS also had higher levels of protective ferroptosis markers in the lung. These data suggest that AEC2 cell FASN modulates the response of the lung to smoke by regulating the composition of the surfactant phospholipidome.

Authors

Li-Chao Fan, Keith McConn, Maria Plataki, Sarah Kenny, Niamh C. Williams, Kihwan Kim, Jennifer A. Quirke, Yan Chen, Maor Sauler, Matthias E. Möbius, Kuei-Pin Chung, Estela Area Gomez, Augustine M.K. Choi, Jin-Fu Xu, Suzanne M. Cloonan

×

Figure 4

Targeted deletion of FASN in AEC2 cells results in age-associated airspace enlargement.

Options: View larger image (or click on image) Download as PowerPoint
Targeted deletion of FASN in AEC2 cells results in age-associated airspa...
(A–D) (A) Schematic of timeline for inspiratory capacity (B), compliance (C), and elastance (D) of 13- to 14-week-old FasniΔAEC2 and SftpcCreERT2+/– control mice (n = 5–6 per group). (E) Schematic and (F) representative IHC modified gills-stained lung sections (left) with mean chord length (MCL) values (right) of 24-month SftpcCreERT2+/– control and FasniΔAEC2 mice (Ctrl n = 9; FasniΔAEC2 n = 13). (G) Schematic of FasniΔAEC2 and control SftpcCreERT2+/– mice fed with high-fat (60%) or low-fat (10%) diet at age 12 months until sacrifice at 18 months. (H) Representative IHC modified gills-stained lung sections and (I) MCL values with (J) representative TUNEL stain and corresponding quantification (right) from FasniΔAEC2 and control SftpcCreERT2+/– mice at 18 months upon supplementation with a high-fat (60%) or low-fat (10%) diet in lung tissue and MCL scoring of mouse lungs for each group. (Ctrl low fat, n = 12; FasniΔAEC2 low fat, n = 11, Ctrl high fat, n = 12, FasniΔAEC2 high fat, n = 7.) Data represented as mean ± SEM of 1 independent experiment. *P < 0.05 by 1-way ANOVA, #P < 0.05 by Student’s unpaired t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts